Most are mild and temporary, like nausea, diarrhea, constipation, or mild bloating. Rare but serious risks (such as severe abdominal pain or allergic reactions) require immediate medical attention.
Download Our App
Mounjaro (tirzepatide) is a once-weekly injectable medication used to support weight loss and blood sugar control. Originally developed for type 2 diabetes, it has shown significant benefits in helping people lose weight, reduce cravings, and improve metabolic health.
This treatment works by mimicking two natural hormones (GIP & GLP-1) that regulate appetite, digestion, and insulin response, making it a popular option for medical weight management programs.
At Dr. Marwah’s Clinic, all Mounjaro treatments are administered under expert supervision, with personalized plans, lifestyle guidance, and regular follow-ups for the best results.
It’s a weekly subcutaneous (under the skin) injection, starting with a low dose and gradually increasing as tolerated.
Typically, 3 to 6 months or longer, depending on your health goals and doctor’s advice.
Adults with BMI ≥ 27 (overweight) with weight-related conditions, or BMI ≥ 30 (obese), especially those who haven’t achieved results through diet and exercise alone.
Not suitable for pregnant or breastfeeding individuals, those with a history of medullary thyroid cancer, MEN2, or pancreatitis, or anyone on certain medications without proper supervision.
Most are mild and temporary, like nausea, diarrhea, constipation, or mild bloating. Rare but serious risks (such as severe abdominal pain or allergic reactions) require immediate medical attention.
Yes. Regular monitoring and lifestyle guidance are provided throughout your program to ensure safe and effective results.
